ANTEROGEN.CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,230 KRW | +3.61% |
|
+5.40% | -10.88% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 596,690 | 371,097 | 566,527 | 605,825 | 143,051 | 166,309 |
| Enterprise Value (EV) 1 | 580,607 | 329,413 | 527,859 | 559,911 | 99,794 | 125,716 |
| P/E ratio | -416 x | -90.3 x | -112 x | -309 x | -20.8 x | -58.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 165 x | 89.5 x | 136 x | 74.6 x | 21.7 x | 25.6 x |
| EV / Revenue | 161 x | 79.4 x | 127 x | 68.9 x | 15.1 x | 19.3 x |
| EV / EBITDA | -306 x | -140 x | -169 x | -310 x | -25.1 x | -29.4 x |
| EV / FCF | -125 x | -43 x | -53.7 x | -97.7 x | -31.5 x | -28.6 x |
| FCF Yield | -0.8% | -2.33% | -1.86% | -1.02% | -3.17% | -3.49% |
| Price to Book | 10.6 x | 5.44 x | 6.99 x | 5.18 x | 1.34 x | 1.28 x |
| Nbr of stocks (in thousands) | 8,440 | 8,650 | 9,094 | 9,422 | 9,731 | 9,731 |
| Reference price 2 | 70,700 | 42,900 | 62,300 | 64,300 | 14,700 | 17,090 |
| Announcement Date | 19-03-01 | 20-02-29 | 21-03-01 | 22-03-01 | 23-03-01 | 24-02-29 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3,607 | 4,148 | 4,151 | 8,122 | 6,591 | 6,500 |
| EBITDA 1 | -1,900 | -2,358 | -3,120 | -1,806 | -3,971 | -4,273 |
| EBIT 1 | -2,489 | -2,955 | -3,736 | -2,633 | -4,734 | -5,104 |
| Operating Margin | -69% | -71.25% | -90% | -32.42% | -71.82% | -78.51% |
| Earnings before Tax (EBT) 1 | -932.5 | -4,050 | -4,375 | -554 | -6,850 | -2,841 |
| Net income 1 | -961.8 | -4,050 | -4,375 | -554 | -6,837 | -2,841 |
| Net margin | -26.66% | -97.64% | -105.39% | -6.82% | -103.73% | -43.7% |
| EPS 2 | -170.0 | -475.0 | -557.0 | -208.0 | -705.9 | -291.9 |
| Free Cash Flow 1 | -4,651 | -7,660 | -9,826 | -5,732 | -3,163 | -4,389 |
| FCF margin | -128.95% | -184.67% | -236.7% | -70.58% | -47.99% | -67.52% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19-03-01 | 20-02-29 | 21-03-01 | 22-03-01 | 23-03-01 | 24-02-29 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 16,083 | 41,684 | 38,668 | 45,913 | 43,257 | 40,593 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -4,651 | -7,660 | -9,826 | -5,732 | -3,163 | -4,389 |
| ROE (net income / shareholders' equity) | -1.87% | -6.26% | -5.67% | -0.56% | -6.11% | -2.41% |
| ROA (Net income/ Total Assets) | -1.95% | -1.99% | -2.61% | -1.43% | -2.27% | -2.33% |
| Assets 1 | 49,329 | 203,961 | 167,511 | 38,868 | 301,393 | 121,826 |
| Book Value Per Share 2 | 6,644 | 7,889 | 8,915 | 12,404 | 10,974 | 13,302 |
| Cash Flow per Share 2 | 1,995 | 4,864 | 4,411 | 740.0 | 401.0 | 143.0 |
| Capex 1 | 3,553 | 2,994 | 5,717 | 3,335 | 1,470 | 150 |
| Capex / Sales | 98.51% | 72.18% | 137.72% | 41.06% | 22.31% | 2.3% |
| Announcement Date | 19-03-01 | 20-02-29 | 21-03-01 | 22-03-01 | 23-03-01 | 24-02-29 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -10.88% | 108M | |
| -2.47% | 89.37B | |
| +2.76% | 40.65B | |
| -12.92% | 32.81B | |
| +52.98% | 25B | |
| -16.51% | 15.29B | |
| -8.27% | 12.93B | |
| -42.60% | 11.61B | |
| -12.82% | 11.49B | |
| +4.79% | 8.98B |
- Stock Market
- Equities
- A065660 Stock
- Financials Anterogen.Co.,Ltd.